Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of combination therapy in the management of hypertension.

× No keyword cloud information.

9 in total

1. Extending the rationale of combination therapy to unresponsive erectile dysfunction.

Authors: Christopher Reece; Rajeev Kumar; Diedre Nienow; Ajay Nehra
Journal: Rev Urol Date: 2007

Review 2. Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.

Authors: Eric Judd; Edgar A Jaimes
Journal: Expert Rev Cardiovasc Ther Date: 2012-03

3. Malignant hypertension complicated by acute renal failure.

Authors: Xiao Li; Wen Zhang; Hong Ren; Xiaoxia Pan; Nan Chen
Journal: BMJ Case Rep Date: 2009-06-15

4. Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension.

Authors: Roland E Schmieder; Agnes Jumar; Eva-Maria Fronk; Ana-Filipa Alexandre; Peter Bramlage
Journal: J Clin Hypertens (Greenwich) Date: 2016-10-27 Impact factor: 3.738

5. Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial.

Authors: Harold Bays; Pingjin Gao; Birgit Völker; Michaela Mattheus; Luis M Ruilope; Dingliang Zhu
Journal: Int J Hypertens Date: 2013-04-04 Impact factor: 2.420

6. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.

Authors: YoonJung Choi; SeungHwan Lee; Sang-Min Cho; Won-Ho Kang; Kyu-Yeol Nam; In-Jin Jang; Kyung-Sang Yu
Journal: Drug Des Devel Ther Date: 2016-09-20 Impact factor: 4.162

7. A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.

Authors: Youngkeun Ahn; Yongcheol Kim; Kiyuk Chang; Weon Kim; Moo-Yong Rhee; Kwang Soo Cha; Min Su Hyon; Chi Young Shim; Sung Yun Lee; Doo Il Kim; Sang Wook Kim; Sang-Wook Lim; Kyoo-Rok Han; Sang-Ho Jo; Nae-Hee Lee; Jun Kwan; Taehoon Ahn
Journal: Medicine (Baltimore) Date: 2018-09 Impact factor: 1.817

8. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.

Authors: Woo Youl Kang; Sook Jin Seong; Boram Ohk; Mi-Ri Gwon; Bo Kyung Kim; Sookie La; Hyun-Ju Kim; Seungil Cho; Young-Ran Yoon; Dong Heon Yang; Hae Won Lee
Journal: Drug Des Devel Ther Date: 2018-03-14 Impact factor: 4.162

9. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial.

Authors: Stacey Lockyer; Ian Rowland; Jeremy Paul Edward Spencer; Parveen Yaqoob; Welma Stonehouse
Journal: Eur J Nutr Date: 2016-03-07 Impact factor: 5.614

9 in total